KZR
Price
$4.09
Change
-$0.34 (-7.67%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
32.36M
SAGE
Price
$9.24
Change
+$0.02 (+0.22%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
577.38M
41 days until earnings call
Interact to see
Advertisement

KZR vs SAGE

Header iconKZR vs SAGE Comparison
Open Charts KZR vs SAGEBanner chart's image
Kezar Life Sciences
Price$4.09
Change-$0.34 (-7.67%)
Volume$2.12K
Capitalization32.36M
Sage Therapeutics
Price$9.24
Change+$0.02 (+0.22%)
Volume$45.12K
Capitalization577.38M
KZR vs SAGE Comparison Chart in %
Loading...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KZR vs. SAGE commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KZR is a Hold and SAGE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (KZR: $4.43 vs. SAGE: $9.22)
Brand notoriety: KZR and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KZR: 180% vs. SAGE: 79%
Market capitalization -- KZR: $32.36M vs. SAGE: $577.38M
KZR [@Biotechnology] is valued at $32.36M. SAGE’s [@Biotechnology] market capitalization is $577.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KZR’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 0 green FA rating(s).

  • KZR’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, SAGE is a better buy in the long-term than KZR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KZR’s TA Score shows that 4 TA indicator(s) are bullish while SAGE’s TA Score has 5 bullish TA indicator(s).

  • KZR’s TA Score: 4 bullish, 6 bearish.
  • SAGE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than KZR.

Price Growth

KZR (@Biotechnology) experienced а +8.31% price change this week, while SAGE (@Biotechnology) price change was +1.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

KZR is expected to report earnings on May 13, 2025.

SAGE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAGE($577M) has a higher market cap than KZR($32.4M). SAGE YTD gains are higher at: 69.797 vs. KZR (-34.077). KZR has higher annual earnings (EBITDA): -76.06M vs. SAGE (-358.98M). SAGE has more cash in the bank: 424M vs. KZR (114M). SAGE has less debt than KZR: SAGE (11.9M) vs KZR (14.1M). SAGE has higher revenues than KZR: SAGE (47.4M) vs KZR (0).
KZRSAGEKZR / SAGE
Capitalization32.4M577M6%
EBITDA-76.06M-358.98M21%
Gain YTD-34.07769.797-49%
P/E RatioN/AN/A-
Revenue047.4M-
Total Cash114M424M27%
Total Debt14.1M11.9M118%
FUNDAMENTALS RATINGS
KZR vs SAGE: Fundamental Ratings
KZR
SAGE
OUTLOOK RATING
1..100
1430
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6438
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
24n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZR's Valuation (50) in the Biotechnology industry is in the same range as SAGE (50) in the Pharmaceuticals Other industry. This means that KZR’s stock grew similarly to SAGE’s over the last 12 months.

KZR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SAGE (100) in the Pharmaceuticals Other industry. This means that KZR’s stock grew similarly to SAGE’s over the last 12 months.

KZR's SMR Rating (100) in the Biotechnology industry is in the same range as SAGE (100) in the Pharmaceuticals Other industry. This means that KZR’s stock grew similarly to SAGE’s over the last 12 months.

SAGE's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as KZR (64) in the Biotechnology industry. This means that SAGE’s stock grew similarly to KZR’s over the last 12 months.

SAGE's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as KZR (100) in the Biotechnology industry. This means that SAGE’s stock grew similarly to KZR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KZRSAGE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
72%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMTC0.690.03
+4.80%
NeuroOne Medical Technologies Corp
FIS82.131.63
+2.02%
Fidelity National Information Services
IAC37.120.28
+0.76%
IAC
AOMR9.160.06
+0.66%
Angel Oak Mortgage REIT
BELFA83.11-1.80
-2.12%
Bel Fuse

KZR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZR has been loosely correlated with AMRN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZR
1D Price
Change %
KZR100%
+3.99%
AMRN - KZR
56%
Loosely correlated
+27.26%
CNTB - KZR
47%
Loosely correlated
-1.98%
SAGE - KZR
36%
Loosely correlated
-0.86%
RAPT - KZR
34%
Loosely correlated
+10.48%
CTMX - KZR
34%
Loosely correlated
-0.93%
More